Managers / Q4 2020 · view latest →
Camber Capital Management LP
CIK 0001444043 · 101 HUNTINGTON AVENUE, SUITE 2101, BOSTON, MA, 02199 · 617-717-6600
Reported Value
$2.8B
Q4 2020
Positions
33
Filings on Record
28
2019–present window
Filed
Feb 16, 2021
original filing
Summary
Camber Capital Management LP reported $2.8B in U.S.-listed holdings across 33 positions for Q4 2020.
Its largest position, CHNGUSD, represents 8.5% of the portfolio.
Compared with Q3 2020, the fund opened 6 new positions and exited 10.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 81.8% · $2.3B
- Other · 16.7% · $476M
- ADR · 1.5% · $43M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VTRSVIATRIS INC | NEW | +12.00M | 12.00M | +$225M | $225M |
| WBAWALGREENS BOOTS ALLIANCE INC | NEW | +4.00M | 4.00M | +$160M | $160M |
| GILDGILEAD SCIENCES INC | NEW | +2.50M | 2.50M | +$146M | $146M |
| BMYBRISTOL-MYERS SQUIBB CO | NEW | +2.00M | 2.00M | +$124M | $124M |
| ABBVABBVIE INC | NEW | +1.00M | 1.00M | +$107M | $107M |
| BIIBBIOGEN INC | NEW | +200.0K | 200.0K | +$49M | $49M |
| ANGOANGIODYNAMICS INC | ADDED | +519.5K | 540.4K | +$8M | $8M |
| GLAXOSMITHKLINE PLC | ADDED | +3.05M | 3.50M | +$112M | $129M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2020
28 positions
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q2 2025 | $1.1B | 25 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | under review | 32 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $4M | 39 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $3M | 33 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $4M | 37 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $4M | 36 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $4M | 38 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $3M | 40 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $3M | 38 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $3M | 41 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | under review | 39 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $3.3B | 45 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $2.3B | 40 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $2.8B | 37 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $2.9B | 39 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $3.2B | 39 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $3.0B | 34 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $2.9B | 32 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $2.8B | 33 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $1.9B | 35 | Nov 16, 2020 | RESTATEMENT | changes · EDGAR ↗ |
| Q2 2020 | $1.7B | 30 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $1.7B | 29 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $2.0B | 29 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $1.9B | 34 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $2.1B | 31 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $2.0B | 28 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $2.1B | 36 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.